The goal of any drug delivery system is to provide a therapeutic amount of drug at the target site in the body. It aims to achieve and maintain the desired drug concentration within body for required time period.\[[@ref1][@ref2]\] Matrix tablet system is one of the sustained drug delivery systems and widely used for the conditions where a prolonged drug concentration within the blood is desired i.e. in the conditions like hypertension, rheumatoid arthritis, hyperlipidaemia and many more. Captopril is an angiotensin converting enzyme inhibitor, used in the treatment of hypertension and fulfills all the criterias, required to be formulated as a matrix tablet. Although researchers have formulated captopril as microspheres, elementary osmotic pump tablets and bilayer floating tablets, if ease of scale up and its feasibility issues are considered, matrix tablet is the most suitable formulation.\[[@ref3]--[@ref5]\] Release of a freely soluble drug can be retarded using an appropriate combinations of hydrophilic and hydrophobic polymers matrices.\[[@ref6]--[@ref9]\] In present study, captopril matrix tablets have been formulated using hydrophilic polymer as a matrix forming agent and solution of hydrophobic polymer as a granulating agent.

Materials and Methods {#sec1-1}
=====================

Hydroxypropylmethylcellulose (HPMC) K4M and Ethyl Cellulose (EC) were purchased from Qualikems Pvt Ltd. Captopril was obtained as a gift sample from Astra Lifecare (India) Pvt. Ltd.

Method utilized to manufacture the matrix tablets was wet granulation. HPMC K4M polymer was used as hydrophilic matrix forming agent while solution of hydrophobic polymer EC in ethanol was used as granulating agent. 32 full factorial design was applied to the experiment and total 9 batches of 500 mg tablets were formulated. The two independent factors selected were concentration of matrix forming agent (X~1~) and concentration of solution of granulating agent (X~2~). The dependent variables considered, to optimize the tablets were hardness, % friability and *in vitro* drug dissolution profile.

Results and Discussion {#sec1-2}
======================

The granules prepared were evaluated for flow properties and the compressed tablets were evaluated for hardness, % friability, drug content uniformity, weight variation and *in vitro* dissolution profile. Results of all the parameters are mentioned along with the standard deviation in [Table 2](#T2){ref-type="table"}. It can be seen from the result that granules have flow properties within the range of 'good flow properties' and therefore the blends are suitable for wet granulation. Tablets of each formula were sufficiently hard that they all passed the test of friability.\[[@ref10][@ref11]\] Moreover all the formulae passed the test of weight Variation and content uniformity. Results of *in vitro* drug dissolution showed that as the concentration of the HPMC K4M increases, release of drug is retarted; moreover the increase in concentration of EC solution further retarded the release and so, zero order release could be achieved.
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Conclusion {#sec1-3}
==========

The sustained release matrix tablets of captopril, prepared by wet granulation method, showed acceptable pre-compression properties, post compression properties and satisfactory drug release up to 24 hrs in controlled manner. The multiple regression analysis of the results led to be equations that describe adequately the influence of the selected variables, concentration of HPMC K4M and concentration of EC in ethanol on the responses under study. The check point analysis led to the optimum values (X~1~ at +1 and X~2~ at 0 level i.e. formula F6) of the factors at which the produced tablets showed drug release up to 24 hrs in controlled manner.
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